'Too expensive' cystic fibrosis drug is blocked due to expense

'Cure' costs £182,000 a year, but it enables some with lung condition to lead a normal life

A drug that could transform the lives of hundreds of people with cystic fibrosis is being blocked from use in England because of a battle over cost, it emerged last night.

The EU approved in July the use of Kalydeco, described by campaigners as, in effect, a "cure" for some cystic fibrosis sufferers, but the NHS has not given the green light because of the high cost per patient: £182,000 a year.

Kalydeco, which is available in the United States, Germany and Italy, has been so effective in clinical trials that sufferers have come off the transplant list or been able to walk again after being confined to a wheelchair by the lung disease.

A petition, organised by the Cystic Fibrosis Trust and signed by 12,000 people, was handed to the drug company Vertex on Friday, urging it to reduce the price.

NHS officials from the Clinical Priorities Advisory Group (CPAG) and representatives from Vertex will meet this week to try to resolve the issue. The hold-up is also being blamed on the axing of a commissioning body, Advisory Group for National Specialised Services, which was responsible for approving drugs to small groups of people. The commissioning body Nice, which is responsible for drugs prescribed to 10,000-plus patients, will not take over approval for "low volume" drugs until next April.

More than 9,000 people in the UK have cystic fibrosis, but the Kalydeco drug works on patients with a specific gene mutation, G55ID – known as the "Celtic gene", because it affects a high proportion of people from Celtic backgrounds. About 440 cystic fibrosis sufferers have this mutation and could be helped by the drug.

Among parents to sign the petition were David and Sarah Barker, from Hampshire, whose 12-year-old daughter, Alexandra, has cystic fibrosis and has undergone a trial for Kalydeco since May 2010. Mrs Barker said: "We found out relatively late in Alexandra's life that she had cystic fibrosis. She was six years old and it came as quite a shock. She had been so unwell and the diagnosis was devastating.

"In the six months before she started taking Kalydeco, Alexandra had to have hospital stays every three months for two weeks. After she started taking Kalydeco she had shown improvements within a week. Lung function has gone up and she's thriving. Unless you have a chronically ill child you won't understand, but CF had taken over our lives. We've not only got Alexandra back; we've got our lives back. Her school work has improved and we can look forward to the future, but only if she can continue with this treatment."

In a letter to Vertex, Ed Owen, chief executive of the Cystic Fibrosis Trust, said the CPAG had "accepted the clinical benefits of the treatment, describing it as 'a significant new step in managing cystic fibrosis' and that the treatment 'provides both a long-term quality of life and survival benefit to patients'".

Mr Owen added: "The Cystic Fibrosis Trust's policy on Kalydeco is clear: that all who would benefit should get it as soon as possible, without impacting on funding for general CF care."

Suggested Topics
Life and Style
ebookNow available in paperback
ebooks
ebookPart of The Independent’s new eBook series The Great Composers
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: Photographer / Floorplanner / Domestic Energy Assessor

    £16000 - £25000 per annum: Recruitment Genius: A Photographer/ Floor planner /...

    Ashdown Group: Front-End Developer - Surrey - £40,000

    £30000 - £40000 per annum: Ashdown Group: Front-End Developer - Guildford/Craw...

    Recruitment Genius: Customer Service Assistant

    £13500 - £15000 per annum: Recruitment Genius: A Customer Service Assistant is...

    Recruitment Genius: Sales Executive - OTE £35,000

    £16000 - £35000 per annum: Recruitment Genius: An ambitious and motivated Sale...

    Day In a Page

    Not even the 'putrid throat' could stop the Ross Poldark swoon-fest'

    Not even the 'putrid throat' could stop the Ross Poldark swoon-fest'

    How a costume drama became a Sunday night staple
    Miliband promises no stamp duty for first-time buyers as he pushes Tories on housing

    Miliband promises no stamp duty for first-time buyers

    Labour leader pushes Tories on housing
    Aviation history is littered with grand failures - from the the Bristol Brabazon to Concorde - but what went wrong with the SuperJumbo?

    Aviation history is littered with grand failures

    But what went wrong with the SuperJumbo?
    Fear of Putin, Islamists and immigration is giving rise to a new generation of Soviet-style 'iron curtains' right across Europe

    Fortress Europe?

    Fear of Putin, Islamists and immigration is giving rise to a new generation of 'iron curtains'
    Never mind what you're wearing, it's what you're reclining on

    Never mind what you're wearing

    It's what you're reclining on that matters
    General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband

    Chuka Umunna: A virus of racism runs through Ukip

    The shadow business secretary on the benefits of immigration, humility – and his leader Ed Miliband
    Yemen crisis: This exotic war will soon become Europe's problem

    Yemen's exotic war will soon affect Europe

    Terrorism and boatloads of desperate migrants will be the outcome of the Saudi air campaign, says Patrick Cockburn
    Marginal Streets project aims to document voters in the run-up to the General Election

    Marginal Streets project documents voters

    Independent photographers Joseph Fox and Orlando Gili are uploading two portraits of constituents to their website for each day of the campaign
    Game of Thrones: Visit the real-life kingdom of Westeros to see where violent history ends and telly tourism begins

    The real-life kingdom of Westeros

    Is there something a little uncomfortable about Game of Thrones shooting in Northern Ireland?
    How to survive a social-media mauling, by the tough women of Twitter

    How to survive a Twitter mauling

    Mary Beard, Caroline Criado-Perez, Louise Mensch, Bunny La Roche and Courtney Barrasford reveal how to trounce the trolls
    Gallipoli centenary: At dawn, the young remember the young who perished in one of the First World War's bloodiest battles

    At dawn, the young remember the young

    A century ago, soldiers of the Empire – many no more than boys – spilt on to Gallipoli’s beaches. On this 100th Anzac Day, there are personal, poetic tributes to their sacrifice
    Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves

    Follow the money as never before

    Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves, reports Rupert Cornwell
    Samuel West interview: The actor and director on austerity, unionisation, and not mentioning his famous parents

    Samuel West interview

    The actor and director on austerity, unionisation, and not mentioning his famous parents
    General Election 2015: Imagine if the leading political parties were fashion labels

    Imagine if the leading political parties were fashion labels

    Fashion editor, Alexander Fury, on what the leaders' appearances tell us about them
    Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

    Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

    The architect of the HeForShe movement and head of UN Women on the world's failure to combat domestic violence